{"doi":"10.1155/2020/7234625","title":"Pain Experiences and Their Relation to Opioid Misuse Risk and Emotion Dysregulation","abstract":"Pain is a complex, multidimensional experience but often is measured as a unidimensional experience. This study aimed to separately assess the sensory and affective components of pain and identify their relations to important pain-related outcomes, particularly in terms of opioid misuse risk and emotion dysregulation among patients with chronic pain receiving treatment in Appalachia. Two hundred and twelve patients presenting to a multidisciplinary pain center completed the Difficulties in Emotion Regulation Scale (DERS-18), Screener and Opioid Assessment for Patients with Pain—Revised (SOAPP-R), and short-form McGill Pain Questionnaire (SF-MPQ). The sensory experience of pain was unrelated to emotion dysregulation (r = 0.06, <a:math xmlns:a=\"http://www.w3.org/1998/Math/MathML\" id=\"M1\"> <a:mi>p</a:mi> <a:mo>=</a:mo> <a:mn>0.57</a:mn> </a:math> ) and weakly related to opioid misuse risk (r = 0.182, <c:math xmlns:c=\"http://www.w3.org/1998/Math/MathML\" id=\"M2\"> <c:mi>p</c:mi> <c:mo>&lt;</c:mo> <c:mn>0.05</c:mn> </c:math> ). In contrast, the affective experience of pain was moderately related to emotion dysregulation (r = 0.217, <e:math xmlns:e=\"http://www.w3.org/1998/Math/MathML\" id=\"M3\"> <e:mi>p</e:mi> <e:mo>&lt;</e:mo> <e:mn>0.05</e:mn> </e:math> ) and strongly related to opioid misuse risk (r = 0.37, <g:math xmlns:g=\"http://www.w3.org/1998/Math/MathML\" id=\"M4\"> <g:mi>p</g:mi> <g:mo>&lt;</g:mo> <g:mn>0.01</g:mn> </g:math> ). In addition, emotion dysregulation predicted variance in opioid misuse risk above and beyond the affective and sensory experiences of pain ((b = 0.693, <i:math xmlns:i=\"http://www.w3.org/1998/Math/MathML\" id=\"M5\"> <i:mi>p</i:mi> <i:mo>&lt;</i:mo> <i:mn>0.001</i:mn> </i:math> ). The results suggest patients with a strong affective experience versus sensory experience of pain and challenges with emotion regulation may require a more comprehensive intervention to address these underlying components in order to reduce their risk of misusing opioid medications.","journal":"Pain Research and Management","year":2020,"id":85470,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":6,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.923,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2020-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":437351,"name":"Cecelia I. Nelson","orcid":"0000-0002-3375-1287","position":1,"is_corresponding":false},{"id":438485,"name":"Richard T. Gross","orcid":null,"position":2,"is_corresponding":false},{"id":437352,"name":"Alison M. Vargovich","orcid":"0000-0002-9281-9878","position":3,"is_corresponding":false},{"id":437350,"name":"Jonathan Nauser","orcid":"0000-0002-3386-2649","position":0,"is_corresponding":true}],"reference_count":33,"raw_metadata":null,"created_at":"2026-07-18T21:58:16.217017Z","pmid":"33224363","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}